Product candidate Target indication Development status
KRX-0401 (perifosine) Multiple myeloma
Colorectal cancer
Multiple other forms of cancer
Phase 3 ongoing, under SPA
Phase 3 pending, under SPA
Phase 2 trials ongoing
ZerenexTM (ferric citrate) Hyperphosphatemia in patients with end-stage renal disease U.S. Phase 2 complete;
U.S. Phase 3 program pending;
Japan Phase 2 ongoing by sublicensee (JT and Torii)


Copyright © 2009 by Keryx Biopharmaceuticals, Inc.
Update Notice | Disclaimer | Contact Us